News
BHST
7.06
+1.60%
0.11
Weekly Report: what happened at BHST last week (0609-0613)?
Weekly Report · 5d ago
BioHarvest Sciences Schedules Annual General Meeting for June 2025
TipRanks · 06/10 10:32
Weekly Report: what happened at BHST last week (0602-0606)?
Weekly Report · 06/09 11:42
Craig-Hallum Sticks to Their Buy Rating for BioHarvest Sciences (BHST)
TipRanks · 06/04 12:56
BioHarvest Sciences Expands with New Informed Sport-Certified VINIA® DailyChews 2X Formula
TipRanks · 06/04 11:41
BioHarvest Sciences Launches VINIA DailyChews 2X Formula, For Athletes And Individuals With Highly Active Lifestyles
Benzinga · 06/04 11:10
BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
Newsfile · 06/04 11:00
What Makes BioHarvest Sciences Inc. (BHST) a Good Fit for 'Trend Investing'
NASDAQ · 06/03 12:50
Weekly Report: what happened at BHST last week (0526-0530)?
Weekly Report · 06/02 11:52
Weekly Report: what happened at BHST last week (0519-0523)?
Weekly Report · 05/26 11:51
BioHarvest Expands into Fragrance Market with New CDMO Contract
TipRanks · 05/21 13:08
Bioharvest Sciences Announces The Company's Botanical Synthesis CDMO Services Division Has Secured A New Contract To Develop A Plant-Based Fragrance Compound Derived From A Plant That Is Under Significant Threat Due To Over Harvesting And Habitat Loss
Benzinga · 05/21 12:53
BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
Newsfile · 05/21 12:30
BioHarvest Sciences: Investors Remain Unconvinced Post Q1 Earnings Release
Seeking Alpha · 05/19 14:02
Weekly Report: what happened at BHST last week (0512-0516)?
Weekly Report · 05/19 11:40
BioHarvest Sciences: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
TipRanks · 05/19 10:17
BioHarvest Sciences: Strong Growth and Strategic Advancements Justify Buy Rating
TipRanks · 05/17 18:45
Bioharvest Sciences Reports Strong Growth in Earnings Call
TipRanks · 05/17 00:21
BioHarvest Sciences Reports Strong Q1 2025 Growth
TipRanks · 05/16 04:28
BioHarvest outlines path to $11M–$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline
Seeking Alpha · 05/16 03:18
More
Webull provides a variety of real-time BHST stock news. You can receive the latest news about Bioharvest through multiple platforms. This information may help you make smarter investment decisions.
About BHST
BioHarvest Sciences Inc. is a Botanical Synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.